<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">1382141</PMID><DateCompleted><Year>1992</Year><Month>10</Month><Day>19</Day></DateCompleted><DateRevised><Year>2020</Year><Month>07</Month><Day>24</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0022-538X</ISSN><JournalIssue CitedMedium="Print"><Volume>66</Volume><Issue>10</Issue><PubDate><Year>1992</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Journal of virology</Title><ISOAbbreviation>J Virol</ISOAbbreviation></Journal><ArticleTitle>Monoclonal anti-idiotypes induce neutralizing antibodies to enterovirus 70 conformational epitopes.</ArticleTitle><Pagination><StartPage>5744</StartPage><EndPage>5751</EndPage><MedlinePgn>5744-51</MedlinePgn></Pagination><Abstract><AbstractText>Monoclonal antibodies (MAbs) directed against the prototype enterovirus 70 (EV-70) strain J670/71 were generated and characterized in order to produce anti-idiotypic MAbs (MAb2s) for use as surrogate immunogens. Western immunoblot and radioimmunoprecipitation assays suggested that all the MAbs recognize conformational epitopes on the virion surface. An EV-70-neutralizing antibody, MAb/ev-12 (MAb1), was selected for the production of MAb2s. Five MAb2s were selected for their capacities to inhibit the interaction of MAb/ev-12 with EV-70 in dot immunobinding inhibition and immunofluorescence assays. In addition, these five MAb2s inhibited virus neutralization mediated by MAb/ev-12, suggesting that they recognize paratope-associated idiotopes. In competition enzyme immunosorbent assays, none of the five MAb2s recognized other neutralizing and nonneutralizing EV-70-specific MAbs, demonstrating that the MAb2s were specific for private idiotopes. Immunization with each of the MAb2s was carried out for the production of anti-anti-idiotypic antibodies (Ab3). All five MAb2s induced an immune response. Moreover, results suggested that they share idiotopes, since MAb2-MAb/ev-12 binding could be inhibited by homologous as well as heterologous Ab3s. Ab3 sera were shown to possess antibodies capable of immunoprecipitating 35S-labeled viral proteins in the same manner as MAb/ev-12. Nine of 15 mice immunized with MAb2s demonstrated Ab3 neutralizing activity specific for the prototype EV-70 strain, J670/71. The potential application of MAb2s to serve as surrogate immunogens for conformational epitopes is substantiated by the results presented in this report.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wiley</LastName><ForeName>J A</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>National Laboratory for Immunology, Laboratory Center for Disease Control, Ottawa, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hamel</LastName><ForeName>J</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Brodeur</LastName><ForeName>B R</ForeName><Initials>BR</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Virol</MedlineTA><NlmUniqueID>0113724</NlmUniqueID><ISSNLinking>0022-538X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000888">Antibodies, Anti-Idiotypic</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000911">Antibodies, Monoclonal</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000914">Antibodies, Viral</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000956">Antigens, Viral</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000939">Epitopes</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000888" MajorTopicYN="N">Antibodies, Anti-Idiotypic</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000911" MajorTopicYN="N">Antibodies, Monoclonal</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000914" MajorTopicYN="N">Antibodies, Viral</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000956" MajorTopicYN="N">Antigens, Viral</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001345" MajorTopicYN="N">Autoradiography</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015153" MajorTopicYN="N">Blotting, Western</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002478" MajorTopicYN="N">Cells, Cultured</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004770" MajorTopicYN="N">Enterovirus</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000939" MajorTopicYN="N">Epitopes</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005455" MajorTopicYN="N">Fluorescent Antibody Technique</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008253" MajorTopicYN="N">Macaca mulatta</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009500" MajorTopicYN="N">Neutralization Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015531" MajorTopicYN="N">Radioimmunoprecipitation Assay</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010948" MajorTopicYN="N">Viral Plaque Assay</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>1992</Year><Month>10</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>1992</Year><Month>10</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>1992</Year><Month>10</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>1992</Year><Month>10</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">1382141</ArticleId><ArticleId IdType="pmc">PMC241449</ArticleId><ArticleId IdType="doi">10.1128/JVI.66.10.5744-5751.1992</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Bull World Health Organ. 1973;49(4):341-6</Citation><ArticleIdList><ArticleId IdType="pubmed">4368683</ArticleId></ArticleIdList></Reference><Reference><Citation>J Immunol Methods. 1986 Feb 12;86(2):239-41</Citation><ArticleIdList><ArticleId IdType="pubmed">3944476</ArticleId></ArticleIdList></Reference><Reference><Citation>J Immunol. 1983 Dec;131(6):2895-902</Citation><ArticleIdList><ArticleId IdType="pubmed">6358356</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Virol. 1992;122(1-2):163-73</Citation><ArticleIdList><ArticleId IdType="pubmed">1309639</ArticleId></ArticleIdList></Reference><Reference><Citation>J Immunol. 1991 Dec 15;147(12):4256-62</Citation><ArticleIdList><ArticleId IdType="pubmed">1661313</ArticleId></ArticleIdList></Reference><Reference><Citation>J Gen Virol. 1991 Jan;72 ( Pt 1):51-8</Citation><ArticleIdList><ArticleId IdType="pubmed">1703562</ArticleId></ArticleIdList></Reference><Reference><Citation>J Virol. 1991 Dec;65(12):6979-84</Citation><ArticleIdList><ArticleId IdType="pubmed">1719237</ArticleId></ArticleIdList></Reference><Reference><Citation>J Gen Virol. 1990 Nov;71 ( Pt 11):2483-501</Citation><ArticleIdList><ArticleId IdType="pubmed">2254747</ArticleId></ArticleIdList></Reference><Reference><Citation>J Virol. 1990 Sep;64(9):4199-206</Citation><ArticleIdList><ArticleId IdType="pubmed">2384917</ArticleId></ArticleIdList></Reference><Reference><Citation>J Gen Virol. 1986 Jul;67 ( Pt 7):1283-91</Citation><ArticleIdList><ArticleId IdType="pubmed">2425046</ArticleId></ArticleIdList></Reference><Reference><Citation>J Virol. 1988 May;62(5):1845-8</Citation><ArticleIdList><ArticleId IdType="pubmed">2451760</ArticleId></ArticleIdList></Reference><Reference><Citation>Immunol Lett. 1988 Feb;17(2):95-107</Citation><ArticleIdList><ArticleId IdType="pubmed">2452136</ArticleId></ArticleIdList></Reference><Reference><Citation>Viral Immunol. 1989 Fall;2(3):143-61</Citation><ArticleIdList><ArticleId IdType="pubmed">2560913</ArticleId></ArticleIdList></Reference><Reference><Citation>J Med Virol. 1988 Jul;25(3):289-96</Citation><ArticleIdList><ArticleId IdType="pubmed">2844979</ArticleId></ArticleIdList></Reference><Reference><Citation>J Immunol. 1986 Nov 1;137(9):2930-6</Citation><ArticleIdList><ArticleId IdType="pubmed">3020129</ArticleId></ArticleIdList></Reference><Reference><Citation>J Virol Methods. 1987 Feb;15(2):109-20</Citation><ArticleIdList><ArticleId IdType="pubmed">3031109</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaccine. 1988 Jun;6(3):215-20</Citation><ArticleIdList><ArticleId IdType="pubmed">3048008</ArticleId></ArticleIdList></Reference><Reference><Citation>Infect Immun. 1985 Nov;50(2):510-6</Citation><ArticleIdList><ArticleId IdType="pubmed">3932211</ArticleId></ArticleIdList></Reference><Reference><Citation>Bioessays. 1986 Dec;5(6):270-4</Citation><ArticleIdList><ArticleId IdType="pubmed">3551940</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaccine. 1988 Apr;6(2):80-4</Citation><ArticleIdList><ArticleId IdType="pubmed">3291459</ArticleId></ArticleIdList></Reference><Reference><Citation>Virology. 1986 Apr 30;150(2):352-60</Citation><ArticleIdList><ArticleId IdType="pubmed">3962185</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 1970 Aug 15;227(5259):680-5</Citation><ArticleIdList><ArticleId IdType="pubmed">5432063</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Microbiol. 1984 Sep;20(3):405-8</Citation><ArticleIdList><ArticleId IdType="pubmed">6092426</ArticleId></ArticleIdList></Reference><Reference><Citation>J Exp Med. 1984 Nov 1;160(5):1485-94</Citation><ArticleIdList><ArticleId IdType="pubmed">6333484</ArticleId></ArticleIdList></Reference><Reference><Citation>J Virol. 1983 Dec;48(3):660-6</Citation><ArticleIdList><ArticleId IdType="pubmed">6605428</ArticleId></ArticleIdList></Reference><Reference><Citation>J Neurol Neurosurg Psychiatry. 1983 Jul;46(7):599-610</Citation><ArticleIdList><ArticleId IdType="pubmed">6886696</ArticleId></ArticleIdList></Reference><Reference><Citation>J Virol. 1976 Jun;18(3):1160-2</Citation><ArticleIdList><ArticleId IdType="pubmed">178922</ArticleId></ArticleIdList></Reference><Reference><Citation>Viral Immunol. 1990 Summer;3(2):137-46</Citation><ArticleIdList><ArticleId IdType="pubmed">1694428</ArticleId></ArticleIdList></Reference><Reference><Citation>Microb Pathog. 1990 Aug;9(2):81-93</Citation><ArticleIdList><ArticleId IdType="pubmed">1703622</ArticleId></ArticleIdList></Reference><Reference><Citation>Vet Microbiol. 1991 Nov;29(3-4):201-12</Citation><ArticleIdList><ArticleId IdType="pubmed">1722928</ArticleId></ArticleIdList></Reference><Reference><Citation>J Virol. 1986 Jan;57(1):246-57</Citation><ArticleIdList><ArticleId IdType="pubmed">2416951</ArticleId></ArticleIdList></Reference><Reference><Citation>J Immunol. 1987 May 15;138(10):3419-25</Citation><ArticleIdList><ArticleId IdType="pubmed">2437193</ArticleId></ArticleIdList></Reference><Reference><Citation>J Virol. 1989 Jun;63(6):2758-67</Citation><ArticleIdList><ArticleId IdType="pubmed">2470919</ArticleId></ArticleIdList></Reference><Reference><Citation>J Virol. 1988 Jun;62(6):2033-40</Citation><ArticleIdList><ArticleId IdType="pubmed">2835507</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 1985 Sep 12-18;317(6033):145-53</Citation><ArticleIdList><ArticleId IdType="pubmed">2993920</ArticleId></ArticleIdList></Reference><Reference><Citation>J Virol. 1987 Sep;61(9):2747-53</Citation><ArticleIdList><ArticleId IdType="pubmed">3039167</ArticleId></ArticleIdList></Reference><Reference><Citation>Infect Immun. 1988 Jun;56(6):1407-13</Citation><ArticleIdList><ArticleId IdType="pubmed">3286496</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 1985 Mar;82(5):1494-8</Citation><ArticleIdList><ArticleId IdType="pubmed">3871949</ArticleId></ArticleIdList></Reference><Reference><Citation>J Exp Med. 1984 Oct 1;160(4):1195-205</Citation><ArticleIdList><ArticleId IdType="pubmed">6332875</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>